Company: HCTI
Filing Date: 2025-10-02
Form Type: PRE 14C
Source: 0001213900-25-095494
Chunk: 5

Company: Healthcare Triangle, Inc.
Filing Date: 2025-10-02
Form: PRE 14C
Chunk 5
---
 of the Company is c/o Healthcare Triangle, Inc, 7901, Stoneridge Dr, Suite 

# 220, Pleasanton, California 94588. |
| (2) | Entitles the holder to 1,000 votes per share and votes with 
 the common stock as a single class.                         |

| (3) | Represents total ownership percentage with respect to all shares                       
 of common stock, options and Series A Super Voting Preferred Stock, as a single class. |

| (4) | SecureKloud Technologies, Inc. is [●]% owned by SecureKloud       
 Technologies Limited which is a publicly traded company in India. |

| (5) | Includes [●] shares of our common stock underlying stock                          
 options that have vested or are exercisable within 60 days of September 19, 2025. |

| (6) | Includes [●] shares of our common stock underlying stock                          
 options that have vested or are exercisable within 60 days of September 19, 2025. |

| (7) | Includes [●] shares of our common stock underlying stock                          
 options that have vested or are exercisable within 60 days of September 19, 2025. |

| (8) | Includes [●]shares of our common stock underlying stock                           
 options that have vested or are exercisable within 60 days of September 19, 2025. |

<div align='center'>3

INTERESTS OF CERTAIN PERSONS IN OR OPPOSITION TO

MATTERS TO BE ACTED UPON</div>

None of the persons who have served as our officers
or directors since the beginning of our last fiscal year, or any associates of such persons, have any substantial interest, direct or
indirect, in the authorization and approval of the Transaction, other than the interests held by such persons through their respective
beneficial ownership of the shares of our capital stock set forth above in the section entitled “Security Ownership of Certain
Beneficial Owners and Management.” None of our directors opposed the authorization and approval of the Transaction.

<div align='center'>VOTE OBTAINED — DELAWARE LAW</div>

Section 228 of the DGCL generally provides that
any action required to be taken at a meeting of stockholders may be taken without a meeting, without prior notice and without a vote,
if a written consent thereto is signed by stockholders having not less than the minimum number of votes that would be necessary to authorize
or take such